Category: Regenerative Treatments

PRP is not one product. Platelet dose, leukocyte profile, red cell contamination, and pre-activation change what reaches the joint, and what the studies show.

A data review before the session, a 60-minute physician-led root-cause discussion, and a written terrain roadmap naming the bottlenecks and the sequence.

In a 2026 survey of 357 orthopedic patients, 66.9% believed orthobiologics could treat cartilage injuries. How we decide when an injection does not fit.

PRP results for tennis elbow depend on when you measure and who was enrolled. The trial-by-trial eligibility and exclusion criteria, stated plainly.

In a MOST analysis of 395 knees, 66% of bone marrow lesions changed size over 30 months and half resolved. How to read the finding on your report.

Level I evidence supports PRP in rotator cuff tears and discourages it in Achilles and patellar tears. Why the injection target decides what the data mean.

Why there is no single recovery schedule after PRP, BMAC or Lipogems, what the phases actually are, and the survey data on what patients wrongly expect.

A staged return-to-lifting plan after PRP, BMAC or Lipogems: readiness checks, three loading stages, knee and disc modifications, and the signs that mean stop.

SI joint pain drives 15-25% of back pain, yet only 45% of fusion patients had a diagnostic injection first. Why confirmation comes before PRP or BMAC.

Heel pain that did not respond to first-line care: where PRP, BMAC and Lipogems actually sit in the published treatment sequence, and what has to be confirmed first.

How much protein, distributed how, and how often to lift — the sourced numbers behind protecting muscle after 30, and what to do when joint pain is the real limit.

Osteoporosis affects 12.6% of US adults aged 50 and over, and low bone mass a further 43.1%. What that means when you are being evaluated for a degenerating joint.

The three are not interchangeable. The selection follows the tissue target, and one randomized knee trial compared BMAC, PRP, and hyaluronic acid over 12 months.

Most studies report around 75% success with non-operative treatment of rotator cuff tears. What that aggregate means, and where orthobiologics genuinely enter.

Nicotine reduced vascularity and left healed tendon 44.7% weaker in a rat model. In human bone-forming cells it was whole smoke, not nicotine, that did the damage.

Your Kellgren-Lawrence grade describes what a knee X-ray shows, not how much pain you feel. What grades 0 to 4 mean, and how reliable the number really is.

In knee osteoarthritis, leukocyte-rich and leukocyte-poor PRP have not separated on pain or function, but local reactions differ. What the trial evidence says.

How micro-fragmented adipose tissue is processed, what the published cluster sizes are, and what it is not claimed to do for an arthritic knee.

PRP placed into subchondral bone, not just the joint space. What the randomized trials on both sides show, who they excluded, and why it is a bridge and not cartilage repair.

Orthobiologics are made from your own blood, marrow, or fat. How collection, timing, sterility, and injection target change what ends up in the syringe.

A 2026 meta-analysis of 821 adults on obesity-dose GLP-1 receptor agonists reported a mean 1.74 kg fall in absolute lean mass. What that means for your plan.

Tendon pathology is present in 88% to 98% of lateral hip pain and isolated bursitis in about 2%. What that changes about which orthobiologic is worth discussing.

Facet joints are the pain source in 15% to 41% of patients with chronic low back pain. What confirming that changes, and where orthobiologics honestly fit.

BMAC is an autologous concentrate, and it does not regrow or regenerate cartilage. What a 2025 narrative review establishes about knee osteoarthritis, and what it does not.

Cervical facet pain: one randomized PRP trial, three series, and the metabolically complex patients every one of them screened out. St. Louis.

Across 9 trials of insertional Achilles tendinopathy, overall certainty for non-surgical care was very low. What that means before you consider an injection.

In 90 patients with grade 3-4 knee osteoarthritis on arthroplasty waiting lists, two PRP injections beat steroid and NSAID at six months. A bridge, not a swap.

Orthobiologics at Regen.MD in St. Louis are biological repair therapies. We place them using high-resolution ultrasound and live X-ray (fluoroscopy). That way the payload lands in the structure it was meant for. Peptides, hormone optimization and light therapy…

Intradiscal PRP at Regen.MD places high-dose leukocyte-rich PRP into the disc. We take 80 cc of your blood and concentrate it to 2 cc. Gentamicin, an antibiotic, is mixed into the contrast dye to target C. acnes bacteria.…

Focused shockwave therapy sends strong sound pressure waves into the tendon. It turns a stuck chronic tendinopathy into a fresh injury your body can repair. (A tendinopathy is a worn, non-healing tendon.) It sparks new blood vessels and…

A store-bought red light panel is truly good for skin, surface blood flow and mild recovery. But it lacks the power density (power packed into each spot) to reach a low back disc, a hip capsule or a…

Clinical-grade whole body vibration works on joint pain when hertz, amplitude and duration are set for you. Hertz is speed, amplitude is how far the plate moves, and duration is time. Set right, it turns force into an…

Yes, you can use an HSA for PRP and stem cell therapy when you are treating a real degenerative condition such as osteoarthritis or severe tendon damage. Under IRS Code Section 213(d), HSA use does not depend on…